Results 121 to 130 of about 24,248 (200)

A modelling assessment of short- and medium-term risks of programme interruptions for gambiense human African trypanosomiasis in the DRC. [PDF]

open access: yesPLoS Negl Trop Dis, 2023
Huang CI   +7 more
europepmc   +1 more source

Urban Transmission of Human African Trypanosomiasis, Gabon

open access: yesEmerging Infectious Diseases, 2012
Fabrice Simon   +6 more
doaj   +1 more source

Prospective evaluation of 2nd generation rapid diagnostic tests for the serological diagnosis of gambiense human African trypanosomiasis in the Democratic Republic of the Congo. [PDF]

open access: yesBMC Infect Dis
Tablado Alonso S   +13 more
europepmc   +1 more source

SHERLOCK4HAT: A CRISPR-based tool kit for diagnosis of Human African Trypanosomiasis. [PDF]

open access: yesEBioMedicine, 2022
Sima N   +5 more
europepmc   +1 more source

Use of fexinidazole in gambiense human African trypanosomiasis: a retrospective analysis of cases treated in Lui Hospital, South Sudan (2018-2024). [PDF]

open access: yesInfection
Mariotti F   +11 more
europepmc   +1 more source

Development of a 2,4-Diaminothiazole Series for the Treatment of Human African Trypanosomiasis Highlights the Importance of Static-Cidal Screening of Analogues. [PDF]

open access: yesJ Med Chem, 2023
Cleghorn LAT   +21 more
europepmc   +1 more source

Human African Trypanosomiasis in Areas without Surveillance

open access: yesEmerging Infectious Diseases, 2010
François Chappuis   +3 more
doaj   +1 more source

Development and validation of a sample-to-result real time multiplex RT-PCR test for human African trypanosomiasis and arboviral febrile illnesses in the Democratic Republic of the Congo. [PDF]

open access: yesBMC Infect Dis
Hauner A   +13 more
europepmc   +1 more source

Structure-Activity Relationships, Tolerability and Efficacy of Microtubule-Active 1,2,4-Triazolo[1,5-a]pyrimidines as Potential Candidates to Treat Human African Trypanosomiasis. [PDF]

open access: yesChemMedChem, 2023
Monti L   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy